Timo Minssen (Former)
61 – 70 of 103
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Life after Myriad: the uncertain future of patenting biomedical innovation and personalised medicine in an international context
(
- Contribution to journal › Article
-
Mark
Enforcing patents in the era of 3D printing
(
- Contribution to journal › Article
-
Mark
IPRs in Biobanking: Risks and Opportunities for Translational Research
(
- Contribution to journal › Article
-
Mark
Standardization, IPRs and open innovation in synthetic biology
2015) p.34-66(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
A “ray of hope” for European stem cell patents or “out of the smog into the fog”?: The CJEU decision in C-364/13 and how it compares to recent US developments.(under review)
2015) In Biotechnology Law Report(
- Contribution to journal › Article
-
Mark
Synthetic biology and intellectual property rights: Six recommendations
(
- Contribution to journal › Article
- 2014
-
Mark
Book Review: Drexl, J., Lee, N. (2013). Pharmaceutical Innovation, Competition and Patent Law : A Trilateral Perspective. Edward Elgar Publishing
(
- Contribution to journal › Review (Book/Film/Exhibition/etc.)
-
Mark
The ”opt out” and “opt in” provisions in the Unified Patent Court Agreement – Impact and strategies for European patent portfolios
(
- Contribution to journal › Article
-
Mark
Legal aspects of biobanking as key issues for personalized medicine and translational exploitation
(
- Contribution to journal › Article
- 2012
-
Mark
Assessing the Inventiveness of Bio-Pharmaceuticals under European and US Patent Law - A comparative study with special emphasis on DNA- and protein-related inventions
2012)(
- Thesis › Doctoral thesis (monograph)